Histamine-2 Receptor Antagonist [EPC]

Histamine-2 Receptor Antagonist [EPC] was reported 131532 times

Drugs of the Histamine-2 Receptor Antagonist [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 292 0.2750
1 NEPHROGENIC ANAEMIA 1068 0.2303
2 REBOUND ACID HYPERSECRETION 690 0.2279
3 HYPERPARATHYROIDISM SECONDARY 531 0.2117
4 MAST CELL ACTIVATION SYNDROME 204 0.1453
5 END STAGE RENAL DISEASE 2440 0.1336
6 CHRONIC KIDNEY DISEASE 8179 0.1075
7 CALCIUM DEFICIENCY 135 0.1042
8 ACCIDENTAL DRUG INTAKE BY CHILD 133 0.0866
9 INFUSION SITE DISCHARGE 136 0.0775
10 CULTURE URINE POSITIVE 88 0.0626
11 RENAL INJURY 1840 0.0619
12 APLASTIC ANAEMIA 317 0.0606
13 ESSENTIAL HYPERTENSION 105 0.0573
14 INFUSION SITE HAEMORRHAGE 167 0.0507
15 INFUSION SITE SWELLING 304 0.0483
16 TUBULOINTERSTITIAL NEPHRITIS 897 0.0478
17 INFUSION SITE PRURITUS 146 0.0462
18 INFUSION SITE BRUISING 89 0.0412
19 INFUSION SITE PAIN 519 0.0402
20 DEVICE INFUSION ISSUE 98 0.0395
21 INFUSION SITE ERYTHEMA 330 0.0391
22 GASTROINTESTINAL HYPOMOTILITY 87 0.0386
23 GASTROOESOPHAGEAL REFLUX DISEASE 3073 0.0381
24 VITAMIN D DEFICIENCY 365 0.0374
25 RENAL FAILURE 4968 0.0374
26 PEPTIC ULCER 123 0.0370
27 ACUTE KIDNEY INJURY 5664 0.0370
28 NEPHROPATHY 329 0.0352
29 IMPAIRED GASTRIC EMPTYING 466 0.0341
30 RHINOVIRUS INFECTION 125 0.0321
31 ATELECTASIS 307 0.0317
32 HYPERVOLAEMIA 156 0.0315
33 RENAL TUBULAR NECROSIS 308 0.0314
34 MONOCYTE COUNT INCREASED 114 0.0314
35 CHOLECYSTITIS CHRONIC 209 0.0312
36 SPINAL OSTEOARTHRITIS 272 0.0309
37 SEASONAL ALLERGY 434 0.0306
38 INTERVERTEBRAL DISC DEGENERATION 282 0.0304
39 CHOLECYSTITIS ACUTE 168 0.0296
40 VITAMIN B12 DEFICIENCY 120 0.0296
41 INFUSION SITE REACTION 87 0.0291
42 URINE ABNORMALITY 127 0.0279
43 BONE LESION 100 0.0277
44 PRODUCT ADMINISTRATION INTERRUPTED 217 0.0276
45 HAEMOGLOBIN INCREASED 126 0.0276
46 PHARYNGEAL SWELLING 269 0.0275
47 BLOOD CREATININE DECREASED 86 0.0274
48 TYPE I HYPERSENSITIVITY 95 0.0270
49 OSTEOPENIA 409 0.0269
50 HYPERLIPIDAEMIA 322 0.0269
51 DISSEMINATED INTRAVASCULAR COAGULATION 377 0.0268
52 VASCULAR DEVICE INFECTION 120 0.0264
53 ACUTE RESPIRATORY FAILURE 508 0.0264
54 BLOOD MAGNESIUM DECREASED 225 0.0260
55 PROTEIN TOTAL DECREASED 98 0.0260
56 RED CELL DISTRIBUTION WIDTH INCREASED 108 0.0260
57 HYPERURICAEMIA 105 0.0255
58 LEFT VENTRICULAR HYPERTROPHY 108 0.0252
59 AORTIC VALVE INCOMPETENCE 107 0.0251
60 MULTIPLE FRACTURES 407 0.0247
61 DIVERTICULUM INTESTINAL 108 0.0247
62 BLOOD LACTATE DEHYDROGENASE INCREASED 391 0.0247
63 IMPAIRED QUALITY OF LIFE 354 0.0246
64 HYPOMAGNESAEMIA 342 0.0245
65 RHINITIS ALLERGIC 109 0.0245
66 HIATUS HERNIA 317 0.0245
67 BONE DISORDER 443 0.0243
68 BLOOD UREA INCREASED 405 0.0242
69 TRICUSPID VALVE INCOMPETENCE 192 0.0241
70 OSTEOPOROSIS 993 0.0241
71 HAEMATOCRIT DECREASED 472 0.0238
72 BLOOD ALBUMIN DECREASED 188 0.0237
73 ECONOMIC PROBLEM 357 0.0235
74 LYMPHOCYTE COUNT DECREASED 407 0.0230
75 GLUCOSE TOLERANCE IMPAIRED 134 0.0226
76 DYSPEPSIA 2229 0.0226
77 MOUTH HAEMORRHAGE 166 0.0226
78 DERMATITIS CONTACT 258 0.0226
79 HYPOPHOSPHATAEMIA 167 0.0226
80 HYPOVOLAEMIA 131 0.0224
81 RENAL FAILURE CHRONIC 171 0.0222
82 TORSADE DE POINTES 174 0.0222
83 HYPOALBUMINAEMIA 171 0.0220
84 BRAIN FOG 343 0.0219
85 GASTRITIS 574 0.0218
86 FOOD ALLERGY 168 0.0217
87 HEREDITARY ANGIOEDEMA 231 0.0215
88 SCOLIOSIS 133 0.0214
89 PROTEIN URINE PRESENT 107 0.0214
90 ANAPHYLACTIC REACTION 1185 0.0214
91 SYNOVIAL CYST 99 0.0214
92 STAPHYLOCOCCAL BACTERAEMIA 93 0.0214
93 MITRAL VALVE INCOMPETENCE 241 0.0213
94 ENTEROCOLITIS 122 0.0211
95 POST-TRAUMATIC STRESS DISORDER 141 0.0210
96 RENAL CYST 167 0.0210
97 DIVERTICULUM 148 0.0208
98 FEBRILE NEUTROPENIA 1381 0.0208
99 HEPATIC FUNCTION ABNORMAL 772 0.0207
100 MULTIPLE ALLERGIES 162 0.0206
101 PERIORBITAL SWELLING 116 0.0205
102 ASPARTATE AMINOTRANSFERASE INCREASED 1084 0.0204
103 PHYSICAL DISABILITY 90 0.0203
104 COMPRESSION FRACTURE 109 0.0203
105 SPINAL COMPRESSION FRACTURE 168 0.0203
106 ANHEDONIA 533 0.0203
107 HOSPICE CARE 200 0.0202
108 HYPOXIA 712 0.0202
109 BLOOD ALKALINE PHOSPHATASE INCREASED 499 0.0201
110 BLOOD PRESSURE SYSTOLIC DECREASED 91 0.0200
111 WEIGHT FLUCTUATION 208 0.0199
112 CARDIOMEGALY 244 0.0198
113 CLOSTRIDIUM DIFFICILE COLITIS 210 0.0198
114 RED BLOOD CELL COUNT DECREASED 566 0.0198
115 PATHOLOGICAL FRACTURE 100 0.0197
116 UPPER-AIRWAY COUGH SYNDROME 162 0.0196
117 CYTOKINE RELEASE SYNDROME 394 0.0196
118 INFUSION RELATED REACTION 1293 0.0195
119 PERIPHERAL VASCULAR DISORDER 100 0.0194
120 DIABETIC NEUROPATHY 96 0.0194
121 MALNUTRITION 216 0.0193
122 LUNG INFILTRATION 170 0.0192
123 BLOOD URIC ACID INCREASED 111 0.0192
124 FOOT FRACTURE 364 0.0192
125 FAILURE TO THRIVE 99 0.0190
126 ALANINE AMINOTRANSFERASE INCREASED 1167 0.0190
127 STAPHYLOCOCCAL SEPSIS 93 0.0188
128 VENTRICULAR TACHYCARDIA 310 0.0188
129 ABDOMINAL TENDERNESS 93 0.0187
130 PROTHROMBIN TIME PROLONGED 112 0.0187
131 NEUTROPHIL COUNT INCREASED 191 0.0186
132 BLOOD POTASSIUM DECREASED 559 0.0186
133 PRE-EXISTING CONDITION IMPROVED 116 0.0186
134 KIDNEY TRANSPLANT REJECTION 89 0.0185
135 SINUS TACHYCARDIA 263 0.0185
136 PNEUMONIA BACTERIAL 170 0.0185
137 DECUBITUS ULCER 150 0.0184
138 MUCOSAL INFLAMMATION 473 0.0180
139 NEUTROPHIL COUNT DECREASED 735 0.0180
140 IRON DEFICIENCY ANAEMIA 166 0.0180
141 OROPHARYNGEAL DISCOMFORT 162 0.0179
142 MENTAL STATUS CHANGES 497 0.0179
143 ILEUS 222 0.0178
144 URINE OUTPUT DECREASED 156 0.0178
145 GALLBLADDER DISORDER 318 0.0178
146 SMALL INTESTINAL OBSTRUCTION 219 0.0178
147 FLANK PAIN 166 0.0177
148 HYPOKALAEMIA 814 0.0176
149 PLATELET COUNT DECREASED 1877 0.0176
150 UPPER RESPIRATORY TRACT INFECTION 813 0.0176
151 RESPIRATORY SYNCYTIAL VIRUS INFECTION 153 0.0176
152 HAND FRACTURE 124 0.0175
153 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 95 0.0174
154 ARTERIOSCLEROSIS 164 0.0174
155 ANGINA UNSTABLE 113 0.0174
156 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 88 0.0174
157 PULMONARY HYPERTENSION 362 0.0174
158 HYPERCHLORHYDRIA 102 0.0173
159 PNEUMOTHORAX 272 0.0171
160 ANOREXIA 220 0.0171
161 OXYGEN SATURATION DECREASED 959 0.0170
162 THROAT TIGHTNESS 458 0.0169
163 PSYCHOLOGICAL TRAUMA 146 0.0169
164 HYPERKERATOSIS 93 0.0168
165 SLEEP APNOEA SYNDROME 321 0.0168
166 PNEUMONIA ASPIRATION 420 0.0168
167 POLYP 110 0.0168
168 EOSINOPHIL COUNT INCREASED 140 0.0168
169 ORAL CANDIDIASIS 221 0.0168
170 OSTEOARTHRITIS 711 0.0168
171 OESOPHAGITIS 183 0.0167
172 INSURANCE ISSUE 256 0.0167
173 NERVE COMPRESSION 153 0.0166
174 DYSLIPIDAEMIA 84 0.0165
175 INCREASED TENDENCY TO BRUISE 152 0.0165
176 BLOOD SODIUM DECREASED 311 0.0165
177 WHITE BLOOD CELL COUNT INCREASED 633 0.0165
178 BLOOD CALCIUM DECREASED 185 0.0164
179 GASTROINTESTINAL MOTILITY DISORDER 88 0.0164
180 ROTATOR CUFF SYNDROME 211 0.0164
181 VENTRICULAR EXTRASYSTOLES 170 0.0164
182 MULTI-ORGAN FAILURE 283 0.0164
183 COVID-19 PNEUMONIA 193 0.0163
184 TASTE DISORDER 331 0.0163
185 LEUKOCYTOSIS 295 0.0163
186 CHOLECYSTITIS 194 0.0163
187 THROAT IRRITATION 730 0.0163
188 DECREASED ACTIVITY 175 0.0162
189 GASTRIC ULCER 308 0.0162
190 DIZZINESS POSTURAL 157 0.0162
191 ECCHYMOSIS 111 0.0162
192 BACTERAEMIA 192 0.0162
193 PURPURA 143 0.0161
194 CHOLELITHIASIS 530 0.0161
195 CARPAL TUNNEL SYNDROME 226 0.0161
196 CELLULITIS 811 0.0161
197 LIGAMENT SPRAIN 159 0.0161
198 BLOOD BILIRUBIN INCREASED 434 0.0160
199 MUSCULOSKELETAL CHEST PAIN 248 0.0160
200 ERUCTATION 310 0.0160
201 SUPRAVENTRICULAR TACHYCARDIA 153 0.0160
202 HYDRONEPHROSIS 119 0.0159
203 CYSTIC FIBROSIS 88 0.0159
204 DYSPNOEA EXERTIONAL 598 0.0159
205 FAECES DISCOLOURED 343 0.0158
206 NOCTURIA 192 0.0158
207 PLEURAL EFFUSION 961 0.0158
208 HEART RATE ABNORMAL 88 0.0158
209 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 162 0.0158
210 INTERVERTEBRAL DISC PROTRUSION 343 0.0157
211 RENAL IMPAIRMENT 1315 0.0156
212 GASTROENTERITIS 227 0.0155
213 ARTERIOSCLEROSIS CORONARY ARTERY 103 0.0155
214 HAEMORRHOIDS 303 0.0155
215 FAECALOMA 85 0.0155
216 THERAPEUTIC RESPONSE UNEXPECTED 691 0.0154
217 PAIN IN JAW 436 0.0154
218 CORONARY ARTERY DISEASE 465 0.0153
219 TENDERNESS 160 0.0153
220 HICCUPS 126 0.0153
221 TUMOUR LYSIS SYNDROME 135 0.0153
222 ACIDOSIS 117 0.0153
223 ATRIAL FLUTTER 122 0.0153
224 DEHYDRATION 2035 0.0152
225 ANKLE FRACTURE 236 0.0152
226 APPETITE DISORDER 101 0.0152
227 ELECTROLYTE IMBALANCE 177 0.0152
228 CONCOMITANT DISEASE AGGRAVATED 94 0.0152
229 BLOOD POTASSIUM INCREASED 247 0.0152
230 CONSTIPATION 3305 0.0151
231 RALES 88 0.0151
232 RESPIRATORY FAILURE 1105 0.0151
233 DERMATITIS ACNEIFORM 92 0.0151
234 INFUSION SITE EXTRAVASATION 94 0.0151
235 EMPHYSEMA 152 0.0151
236 TOXIC EPIDERMAL NECROLYSIS 228 0.0150
237 CHEST DISCOMFORT 1528 0.0149
238 INTERSTITIAL LUNG DISEASE 722 0.0149
239 SKIN LACERATION 162 0.0149
240 FLATULENCE 841 0.0148
241 GINGIVAL PAIN 118 0.0148
242 SINUS BRADYCARDIA 143 0.0148
243 WHITE BLOOD CELL COUNT DECREASED 1603 0.0148
244 ELECTROCARDIOGRAM ABNORMAL 116 0.0148
245 RIB FRACTURE 304 0.0148
246 BLOOD IRON DECREASED 175 0.0147
247 ORAL PAIN 328 0.0146
248 RENAL FAILURE ACUTE 619 0.0146
249 PSEUDOMONAS INFECTION 125 0.0146
250 HAEMOGLOBIN DECREASED 1496 0.0146
251 SINUS DISORDER 288 0.0145
252 GENERALISED OEDEMA 180 0.0145
253 POOR VENOUS ACCESS 150 0.0145
254 URINARY TRACT INFECTION 2471 0.0145
255 SEPSIS 1614 0.0145
256 DRY THROAT 147 0.0144
257 BLOOD CREATININE INCREASED 943 0.0144
258 WRIST FRACTURE 173 0.0144
259 HAEMOPTYSIS 402 0.0144
260 MUSCULOSKELETAL DISCOMFORT 248 0.0144
261 RETCHING 307 0.0144
262 HEPATIC STEATOSIS 267 0.0143
263 TRANSFUSION 150 0.0143
264 WALKING AID USER 94 0.0142
265 SENSATION OF FOREIGN BODY 120 0.0142
266 BLOOD PRESSURE DIASTOLIC DECREASED 105 0.0142
267 RESPIRATION ABNORMAL 98 0.0142
268 ENCEPHALOPATHY 349 0.0142
269 FLUSHING 1440 0.0142
270 PRODUCTIVE COUGH 676 0.0141
271 PROCTALGIA 91 0.0141
272 WHITE BLOOD CELL COUNT ABNORMAL 90 0.0141
273 LIVER DISORDER 623 0.0140
274 DRUG SCREEN POSITIVE 111 0.0140
275 VITAMIN D DECREASED 120 0.0140
276 ARTHROPOD BITE 104 0.0140
277 MENISCUS INJURY 86 0.0140
278 RIGHT VENTRICULAR FAILURE 98 0.0140
279 TONGUE DISORDER 101 0.0139
280 MAJOR DEPRESSION 102 0.0139
281 HAEMODIALYSIS 117 0.0139
282 TROPONIN INCREASED 106 0.0139
283 BRONCHITIS 1031 0.0139
284 DENTAL CARIES 154 0.0139
285 ANAL INCONTINENCE 125 0.0139
286 ATRIOVENTRICULAR BLOCK COMPLETE 93 0.0139
287 EAR PAIN 270 0.0139
288 BLOOD PRESSURE ABNORMAL 276 0.0139
289 CARDIAC MURMUR 120 0.0139
290 CORONARY ARTERY OCCLUSION 190 0.0138
291 OLIGURIA 86 0.0138
292 CLOSTRIDIUM DIFFICILE INFECTION 302 0.0138
293 LOWER GASTROINTESTINAL HAEMORRHAGE 102 0.0138
294 GASTROENTERITIS VIRAL 249 0.0138
295 COLITIS ISCHAEMIC 93 0.0138
296 ORAL DISCOMFORT 191 0.0137
297 HAIR COLOUR CHANGES 171 0.0137
298 SPINAL DISORDER 130 0.0137
299 BIPOLAR DISORDER 149 0.0137
300 FULL BLOOD COUNT DECREASED 276 0.0137
301 HYPERCHOLESTEROLAEMIA 132 0.0137
302 PRODUCT DOSE OMISSION IN ERROR 387 0.0137
303 TEMPERATURE INTOLERANCE 141 0.0137
304 STOMATITIS 826 0.0136
305 GAMMA-GLUTAMYLTRANSFERASE INCREASED 301 0.0136
306 EXOSTOSIS 124 0.0136
307 ABDOMINAL DISTENSION 1415 0.0135
308 RESPIRATORY RATE INCREASED 120 0.0135
309 URTICARIA 2263 0.0135
310 SPLENOMEGALY 158 0.0135
311 IRRITABLE BOWEL SYNDROME 289 0.0135
312 VIRAL INFECTION 448 0.0134
313 ULCER 214 0.0134
314 NASAL CONGESTION 790 0.0134
315 UPPER GASTROINTESTINAL HAEMORRHAGE 226 0.0134
316 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 701 0.0134
317 CHEST PAIN 2487 0.0134
318 OSTEOMYELITIS 243 0.0134
319 ERYTHEMA MULTIFORME 125 0.0134
320 ACUTE RESPIRATORY DISTRESS SYNDROME 236 0.0133
321 BLOOD PRESSURE DECREASED 886 0.0133
322 PULMONARY MASS 198 0.0133
323 RESPIRATORY TRACT CONGESTION 211 0.0133
324 BODY HEIGHT DECREASED 142 0.0133
325 PARAESTHESIA ORAL 191 0.0132
326 POOR QUALITY SLEEP 285 0.0132
327 LIP SWELLING 440 0.0132
328 DYSPHAGIA 1251 0.0132
329 POSTOPERATIVE WOUND INFECTION 89 0.0132
330 SWOLLEN TONGUE 411 0.0131
331 CARDIAC FLUTTER 85 0.0131
332 ASPIRATION 144 0.0131
333 VENTRICULAR FIBRILLATION 146 0.0131
334 HYPERKALAEMIA 460 0.0131
335 RESPIRATORY DISTRESS 362 0.0131
336 UROSEPSIS 121 0.0131
337 DECREASED APPETITE 3046 0.0131
338 BURSITIS 159 0.0131
339 ABDOMINAL PAIN UPPER 2690 0.0131
340 TOOTH FRACTURE 144 0.0130
341 CARDIAC FAILURE ACUTE 87 0.0130
342 INCONTINENCE 138 0.0130
343 HYPOCALCAEMIA 247 0.0130
344 EPISTAXIS 976 0.0130
345 PRODUCT DISTRIBUTION ISSUE 121 0.0130
346 DUODENAL ULCER 92 0.0130
347 CYSTITIS 415 0.0130
348 HYPOPHAGIA 333 0.0130
349 NECK PAIN 727 0.0130
350 GOUT 233 0.0130
351 PULMONARY OEDEMA 581 0.0130
352 EAR INFECTION 345 0.0130
353 PANCYTOPENIA 724 0.0129
354 HAEMOLYTIC ANAEMIA 116 0.0129
355 BOWEL MOVEMENT IRREGULARITY 99 0.0129
356 RESPIRATORY TRACT INFECTION 336 0.0129
357 PLATELET COUNT INCREASED 168 0.0129
358 POST PROCEDURAL COMPLICATION 247 0.0128
359 CEREBRAL INFARCTION 314 0.0128
360 ASCITES 377 0.0128
361 RESTLESS LEGS SYNDROME 233 0.0128
362 TACHYPNOEA 174 0.0128
363 ADRENAL INSUFFICIENCY 155 0.0128
364 SINUSITIS 1308 0.0127
365 ATRIAL FIBRILLATION 1242 0.0127
366 ARTHRITIS 1002 0.0127
367 INTENTIONAL DOSE OMISSION 362 0.0127
368 DRUG EFFECT LESS THAN EXPECTED 188 0.0127
369 NEUROPATHY PERIPHERAL 1206 0.0127
370 BACK PAIN 2938 0.0126
371 NEPHROLITHIASIS 580 0.0126
372 COUGH 3546 0.0126
373 BLOOD URINE PRESENT 240 0.0126
374 MYASTHENIA GRAVIS 102 0.0126
375 FEEDING DISORDER 256 0.0126
376 ANAEMIA 2405 0.0126
377 PNEUMONIA 4081 0.0126
378 COVID-19 2211 0.0126
379 BACK INJURY 137 0.0126
380 SEPTIC SHOCK 548 0.0126
381 NEURALGIA 306 0.0126
382 SINUS CONGESTION 170 0.0126
383 LYMPHOEDEMA 87 0.0126
384 SPUTUM DISCOLOURED 119 0.0125
385 DEVICE RELATED INFECTION 193 0.0125
386 OEDEMA 680 0.0125
387 EXPOSURE DURING PREGNANCY 779 0.0125
388 LARGE INTESTINE PERFORATION 87 0.0125
389 PNEUMONITIS 341 0.0125
390 HEART RATE INCREASED 1239 0.0125
391 BONE PAIN 732 0.0125
392 EYE PAIN 705 0.0125
393 ILLNESS 1286 0.0125
394 EAR DISCOMFORT 128 0.0125
395 DRUG ERUPTION 221 0.0125
396 GASTROINTESTINAL PAIN 137 0.0124
397 DYSPHONIA 728 0.0124
398 MICTURITION URGENCY 142 0.0124
399 GASTROINTESTINAL INFECTION 111 0.0124
400 ABDOMINAL DISCOMFORT 2076 0.0124
401 FAECES SOFT 90 0.0124
402 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 288 0.0123
403 TACHYCARDIA 1097 0.0123
404 JOINT INJURY 263 0.0123
405 GROIN PAIN 108 0.0123
406 TOOTH ABSCESS 125 0.0123
407 HYPERBILIRUBINAEMIA 127 0.0122
408 COAGULOPATHY 204 0.0122
409 DIVERTICULITIS 339 0.0122
410 EATING DISORDER 260 0.0122
411 DIARRHOEA 7876 0.0122
412 BLOOD THYROID STIMULATING HORMONE INCREASED 112 0.0122
413 MUSCLE STRAIN 105 0.0121
414 LARGE INTESTINE POLYP 84 0.0121
415 MYOCARDIAL ISCHAEMIA 138 0.0121
416 BACTERIAL INFECTION 226 0.0121
417 LIMB INJURY 329 0.0121
418 VITREOUS FLOATERS 119 0.0121
419 PHARYNGITIS 150 0.0121
420 DYSURIA 445 0.0121
421 UNRESPONSIVE TO STIMULI 312 0.0121
422 COLITIS 458 0.0121
423 CHILLS 1415 0.0121
424 THYROID DISORDER 186 0.0121
425 PULMONARY CONGESTION 159 0.0120
426 ACUTE MYOCARDIAL INFARCTION 355 0.0120
427 INTERNATIONAL NORMALISED RATIO INCREASED 343 0.0120
428 RENAL DISORDER 560 0.0120
429 HAIR DISORDER 99 0.0120
430 ANXIETY 3419 0.0120
431 INCORRECT PRODUCT ADMINISTRATION DURATION 260 0.0120
432 CHOLECYSTECTOMY 137 0.0120
433 ABDOMINAL PAIN 2787 0.0120
434 POLYURIA 98 0.0120
435 GLOMERULAR FILTRATION RATE DECREASED 147 0.0120
436 FLUID OVERLOAD 174 0.0119
437 SKIN ULCER 309 0.0119
438 OEDEMA PERIPHERAL 1455 0.0119
439 BACK DISORDER 194 0.0119
440 HYPONATRAEMIA 671 0.0119
441 OROPHARYNGEAL PAIN 1102 0.0119
442 HYPOTHYROIDISM 379 0.0119
443 OBESITY 189 0.0119
444 QUALITY OF LIFE DECREASED 159 0.0118
445 OCULAR DISCOMFORT 133 0.0118
446 INTERNAL HAEMORRHAGE 135 0.0118
447 HEPATOMEGALY 116 0.0118
448 INJURY 828 0.0118
449 TOOTHACHE 213 0.0118
450 FACIAL PAIN 105 0.0118
451 VOMITING 5530 0.0118
452 DRY EYE 587 0.0117
453 TOOTH INFECTION 155 0.0117
454 URINARY INCONTINENCE 348 0.0117
455 BLOOD CALCIUM INCREASED 103 0.0117
456 HYPERCALCAEMIA 145 0.0117
457 STAPHYLOCOCCAL INFECTION 386 0.0117
458 HEART RATE IRREGULAR 264 0.0117
459 HYPOAESTHESIA ORAL 176 0.0117
460 SCIATICA 186 0.0117
461 HYPOTENSION 2338 0.0116
462 HYPERSOMNIA 334 0.0116
463 CYANOSIS 183 0.0116
464 RHINORRHOEA 752 0.0116
465 TRANSIENT ISCHAEMIC ATTACK 391 0.0116
466 HAIR TEXTURE ABNORMAL 155 0.0116
467 PERIPHERAL COLDNESS 159 0.0116
468 CARDIAC FAILURE CONGESTIVE 929 0.0116
469 BONE DENSITY DECREASED 362 0.0115
470 ANAPHYLACTIC SHOCK 297 0.0115
471 PERICARDIAL EFFUSION 266 0.0115
472 FACE OEDEMA 194 0.0115
473 PYREXIA 3964 0.0114
474 EMBOLISM 95 0.0114
475 CARDIOMYOPATHY 169 0.0114
476 PHOTOPHOBIA 215 0.0114
477 SECRETION DISCHARGE 143 0.0114
478 ANGINA PECTORIS 327 0.0114
479 DRY MOUTH 924 0.0114
480 MUSCLE TIGHTNESS 184 0.0113
481 DEPRESSION 2583 0.0113
482 ACUTE CORONARY SYNDROME 94 0.0113
483 NAUSEA 8976 0.0113
484 BLOOD PRESSURE INCREASED 1732 0.0113
485 DELIRIUM 393 0.0113
486 METASTASES TO LIVER 199 0.0113
487 HAEMATEMESIS 287 0.0113
488 CANDIDA INFECTION 191 0.0113
489 PYELONEPHRITIS 98 0.0113
490 ALTERED STATE OF CONSCIOUSNESS 245 0.0113
491 INITIAL INSOMNIA 116 0.0113
492 C-REACTIVE PROTEIN INCREASED 411 0.0113
493 DYSPNOEA 6391 0.0113
494 RHINITIS 91 0.0113
495 PROTEINURIA 214 0.0112
496 FLUID RETENTION 571 0.0112
497 SUBARACHNOID HAEMORRHAGE 114 0.0112
498 BODY TEMPERATURE DECREASED 110 0.0112
499 STEVENS-JOHNSON SYNDROME 248 0.0111
500 HYPERTENSION 2358 0.0111
501 PETECHIAE 116 0.0111
502 LABORATORY TEST ABNORMAL 328 0.0111
503 PULMONARY ARTERIAL HYPERTENSION 161 0.0111
504 PERIPHERAL SWELLING 1709 0.0111
505 BLADDER DISORDER 110 0.0111
506 SARS-COV-2 TEST POSITIVE 146 0.0110
507 SUBDURAL HAEMATOMA 158 0.0110
508 ORAL HERPES 215 0.0110
509 THROMBOCYTOPENIA 1231 0.0110
510 WEIGHT DECREASED 3071 0.0110
511 DYSGEUSIA 816 0.0110
512 SPINAL FRACTURE 220 0.0110
513 BODY TEMPERATURE INCREASED 224 0.0110
514 MIDDLE INSOMNIA 205 0.0110
515 HERNIA 212 0.0110
516 LIPASE INCREASED 84 0.0110
517 PRESYNCOPE 266 0.0109
518 METASTASES TO LUNG 126 0.0109
519 PANCREATITIS ACUTE 245 0.0109
520 BLOOD TRIGLYCERIDES INCREASED 192 0.0109
521 FEELING HOT 666 0.0109
522 HAEMATURIA 372 0.0109
523 CONTUSION 1045 0.0108
524 INTESTINAL OBSTRUCTION 409 0.0108
525 GASTROINTESTINAL HAEMORRHAGE 905 0.0108
526 ANGIOEDEMA 478 0.0108
527 THIRST 193 0.0108
528 SPINAL OPERATION 133 0.0108
529 SWELLING FACE 702 0.0108
530 SWELLING 1009 0.0108
531 MASS 150 0.0107
532 LIMB DISCOMFORT 332 0.0107
533 HERPES ZOSTER 616 0.0107
534 HYPERGLYCAEMIA 390 0.0107
535 DEEP VEIN THROMBOSIS 695 0.0107
536 WHEEZING 634 0.0107
537 HEAD INJURY 338 0.0107
538 FATIGUE 8315 0.0107
539 METASTASES TO BONE 175 0.0107
540 SHOCK 245 0.0106
541 SCAR 182 0.0106
542 BLOOD PRESSURE FLUCTUATION 255 0.0106
543 FIBROMYALGIA 258 0.0106
544 SKIN INFECTION 119 0.0106
545 LACRIMATION INCREASED 320 0.0106
546 CHROMATURIA 239 0.0106
547 EYE DISCHARGE 110 0.0106
548 ESCHERICHIA INFECTION 87 0.0106
549 LETHARGY 608 0.0106
550 MUSCULAR WEAKNESS 1201 0.0106
551 LOWER LIMB FRACTURE 203 0.0106
552 ASTHENIA 3971 0.0106
553 PALPITATIONS 1236 0.0105
554 HIP FRACTURE 339 0.0105
555 MIGRAINE 1006 0.0105
556 NERVE INJURY 117 0.0105
557 POLLAKIURIA 438 0.0105
558 RECTAL HAEMORRHAGE 451 0.0105
559 EYE INFECTION 118 0.0104
560 KIDNEY INFECTION 205 0.0104
561 TOOTH EXTRACTION 130 0.0104
562 LOCALISED INFECTION 252 0.0104
563 DYSSTASIA 304 0.0104
564 BLOOD PRESSURE SYSTOLIC INCREASED 203 0.0104
565 SKIN DISORDER 347 0.0104
566 HYPOAESTHESIA 1557 0.0104
567 IMMUNODEFICIENCY 155 0.0104
568 TOOTH DISORDER 231 0.0104
569 FEELING COLD 289 0.0104
570 DIZZINESS 5175 0.0104
571 DIABETES MELLITUS 790 0.0104
572 URINARY RETENTION 345 0.0103
573 BLOOD TEST ABNORMAL 145 0.0103
574 SHOCK HAEMORRHAGIC 84 0.0103
575 CATARACT 613 0.0103
576 PRODUCT USE COMPLAINT 162 0.0103
577 HEART RATE DECREASED 361 0.0103
578 PHARYNGITIS STREPTOCOCCAL 111 0.0102
579 COORDINATION ABNORMAL 143 0.0102
580 PANIC ATTACK 373 0.0102
581 LYMPHADENOPATHY 362 0.0102
582 BRAIN OEDEMA 129 0.0102
583 DIALYSIS 144 0.0101
584 RESPIRATORY DISORDER 303 0.0101
585 HEMIPLEGIA 84 0.0101
586 HEMIPARESIS 171 0.0101
587 FALL 3359 0.0101
588 PRODUCT PHYSICAL ISSUE 203 0.0101
589 HEAD DISCOMFORT 178 0.0100
590 BALANCE DISORDER 863 0.0100
591 ASTHMA 1127 0.0100
592 HEPATIC ENCEPHALOPATHY 93 0.0100
593 GASTRIC DISORDER 342 0.0100
594 GINGIVAL BLEEDING 136 0.0100
595 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 169 0.0099
596 MELAENA 219 0.0099
597 EYE SWELLING 370 0.0099
598 MUSCLE SPASMS 1825 0.0099
599 ORTHOSTATIC HYPOTENSION 173 0.0099
600 GASTROINTESTINAL DISORDER 890 0.0099
601 FULL BLOOD COUNT ABNORMAL 105 0.0099
602 MADAROSIS 115 0.0099
603 BRADYCARDIA 525 0.0099
604 RASH PRURITIC 536 0.0099
605 DISORIENTATION 391 0.0099
606 PRURITUS 3790 0.0099
607 DEPRESSED LEVEL OF CONSCIOUSNESS 389 0.0098
608 HOT FLUSH 741 0.0098
609 TREMOR 1631 0.0098
610 PULMONARY THROMBOSIS 107 0.0098
611 FUNGAL INFECTION 327 0.0098
612 HYPERSENSITIVITY 1817 0.0098
613 BLOOD CREATINE PHOSPHOKINASE INCREASED 281 0.0098
614 CARDIO-RESPIRATORY ARREST 408 0.0097
615 NIGHT SWEATS 314 0.0097
616 BRONCHOSPASM 139 0.0097
617 NAIL DISORDER 85 0.0097
618 RHABDOMYOLYSIS 405 0.0097
619 COMPLICATION ASSOCIATED WITH DEVICE 141 0.0097
620 SALIVARY HYPERSECRETION 97 0.0097
621 INSOMNIA 2580 0.0097
622 DYSARTHRIA 364 0.0097
623 HEADACHE 6059 0.0097
624 DISEASE PROGRESSION 1141 0.0096
625 SNEEZING 216 0.0096
626 MUSCLE ATROPHY 122 0.0096
627 FEAR 259 0.0096
628 PULMONARY EMBOLISM 914 0.0096
629 HAEMATOMA 249 0.0096
630 INFLUENZA 1070 0.0096
631 TINNITUS 440 0.0096
632 PRODUCT DOSE OMISSION ISSUE 2811 0.0095
633 JOINT DISLOCATION 101 0.0095
634 CEREBRAL HAEMORRHAGE 342 0.0095
635 JAUNDICE 257 0.0095
636 AUTOIMMUNE DISORDER 93 0.0095
637 LUNG DISORDER 467 0.0095
638 HALLUCINATION, VISUAL 201 0.0095
639 SKIN DISCOLOURATION 437 0.0095
640 FEELING JITTERY 181 0.0095
641 HYPERHIDROSIS 1220 0.0095
642 APHONIA 132 0.0094
643 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 454 0.0094
644 IMPAIRED WORK ABILITY 202 0.0094
645 INTESTINAL PERFORATION 106 0.0094
646 CONFUSIONAL STATE 1519 0.0094
647 PULMONARY FIBROSIS 180 0.0094
648 METABOLIC ACIDOSIS 300 0.0094
649 MYALGIA 1591 0.0093
650 ELECTROCARDIOGRAM QT PROLONGED 335 0.0093
651 CYTOPENIA 114 0.0093
652 ARTHRALGIA 3865 0.0093
653 THERAPY INTERRUPTED 664 0.0093
654 SEROTONIN SYNDROME 178 0.0093
655 CYST 115 0.0093
656 BURNING SENSATION 649 0.0092
657 THERAPY CHANGE 91 0.0092
658 OSTEONECROSIS OF JAW 229 0.0092
659 HAEMORRHAGE INTRACRANIAL 138 0.0092
660 PLASMA CELL MYELOMA 358 0.0092
661 BLISTER 515 0.0092
662 CONJUNCTIVITIS 170 0.0092
663 SPEECH DISORDER 480 0.0092
664 PAIN IN EXTREMITY 2699 0.0092
665 PRODUCT PACKAGING ISSUE 87 0.0091
666 RASH MACULAR 320 0.0091
667 GAIT INABILITY 305 0.0091
668 HALLUCINATION 687 0.0091
669 THROMBOSIS 733 0.0091
670 PANCREATITIS 481 0.0091
671 AGEUSIA 227 0.0091
672 UPPER LIMB FRACTURE 181 0.0091
673 THERAPY NON-RESPONDER 408 0.0091
674 METASTASES TO CENTRAL NERVOUS SYSTEM 117 0.0091
675 EYE IRRITATION 522 0.0091
676 SYNCOPE 907 0.0091
677 PRODUCT USE IN UNAPPROVED INDICATION 2246 0.0091
678 TYPE 2 DIABETES MELLITUS 305 0.0091
679 BLOOD CHOLESTEROL INCREASED 421 0.0090
680 POST PROCEDURAL HAEMORRHAGE 105 0.0090
681 PAIN 5540 0.0090
682 APPENDICITIS 84 0.0090
683 COLON CANCER 134 0.0090
684 NASOPHARYNGITIS 1656 0.0090
685 COLD SWEAT 158 0.0090
686 CARDIAC ARREST 739 0.0089
687 DELUSION 139 0.0089
688 RASH 3899 0.0089
689 GLAUCOMA 172 0.0089
690 HEPATIC FAILURE 269 0.0089
691 DISCOMFORT 544 0.0089
692 PRODUCT TASTE ABNORMAL 120 0.0089
693 INFECTION 1282 0.0088
694 MUSCULOSKELETAL PAIN 464 0.0088
695 CYTOMEGALOVIRUS INFECTION 147 0.0088
696 CHOKING 172 0.0088
697 EJECTION FRACTION DECREASED 137 0.0088
698 APHASIA 265 0.0088
699 NEUTROPENIA 1193 0.0088
700 SLEEP DISORDER 618 0.0087
701 LIVER FUNCTION TEST INCREASED 187 0.0087
702 PARAESTHESIA 1370 0.0087
703 DRUG LEVEL INCREASED 144 0.0087
704 RESTLESSNESS 318 0.0087
705 DEVICE OCCLUSION 122 0.0087
706 TENDONITIS 134 0.0086
707 DRUG INTERACTION 1372 0.0086
708 DISEASE RECURRENCE 411 0.0086
709 IMPAIRED HEALING 282 0.0086
710 RASH MACULO-PAPULAR 191 0.0086
711 WOUND INFECTION 94 0.0086
712 ACCIDENTAL OVERDOSE 313 0.0085
713 EMOTIONAL DISTRESS 1035 0.0085
714 VISION BLURRED 1173 0.0085
715 SPINAL PAIN 100 0.0085
716 BASAL CELL CARCINOMA 133 0.0085
717 GAIT DISTURBANCE 1631 0.0085
718 CARDIAC FAILURE 684 0.0085
719 BLOOD COUNT ABNORMAL 129 0.0085
720 HAEMATOCHEZIA 468 0.0085
721 EYE PRURITUS 284 0.0084
722 MOUTH ULCERATION 178 0.0084
723 CARDIOGENIC SHOCK 121 0.0084
724 UNEVALUABLE EVENT 637 0.0084
725 DEMENTIA 235 0.0084
726 DERMATITIS 176 0.0084
727 ERYTHEMA 1724 0.0084
728 SURGERY 491 0.0084
729 ATAXIA 99 0.0083
730 ABSCESS 133 0.0083
731 VERTIGO 507 0.0083
732 FOOT DEFORMITY 92 0.0083
733 LEUKOPENIA 415 0.0083
734 LIVER FUNCTION TEST ABNORMAL 240 0.0082
735 SKIN LESION 226 0.0082
736 LOSS OF CONSCIOUSNESS 1054 0.0082
737 NODULE 107 0.0082
738 SOMNOLENCE 1649 0.0082
739 PHOTOSENSITIVITY REACTION 135 0.0082
740 FEELING ABNORMAL 1958 0.0082
741 SKIN HAEMORRHAGE 121 0.0082
742 MYOCLONUS 97 0.0081
743 PHARYNGEAL OEDEMA 125 0.0081
744 DYSKINESIA 330 0.0081
745 SEIZURE 936 0.0081
746 ALOPECIA 1590 0.0081
747 RESPIRATORY ARREST 223 0.0081
748 GLOSSODYNIA 181 0.0081
749 AMNESIA 525 0.0081
750 WOUND 225 0.0080
751 HEPATIC CIRRHOSIS 151 0.0080
752 HEPATIC ENZYME INCREASED 545 0.0080
753 FEMUR FRACTURE 247 0.0080
754 RASH ERYTHEMATOUS 381 0.0080
755 CONDITION AGGRAVATED 2422 0.0080
756 PARALYSIS 114 0.0080
757 ARRHYTHMIA 376 0.0079
758 DIPLOPIA 206 0.0079
759 TOOTH LOSS 164 0.0079
760 VASCULITIS 92 0.0079
761 MALIGNANT NEOPLASM PROGRESSION 808 0.0079
762 ROAD TRAFFIC ACCIDENT 328 0.0078
763 OBSTRUCTIVE AIRWAYS DISORDER 87 0.0078
764 CIRCULATORY COLLAPSE 133 0.0078
765 LACTIC ACIDOSIS 252 0.0078
766 DRUG-INDUCED LIVER INJURY 244 0.0078
767 RED BLOOD CELL SEDIMENTATION RATE INCREASED 86 0.0078
768 WEIGHT INCREASED 1740 0.0078
769 BEDRIDDEN 102 0.0078
770 PALLOR 211 0.0077
771 ABDOMINAL PAIN LOWER 195 0.0077
772 HYPOGLYCAEMIA 374 0.0077
773 AGRANULOCYTOSIS 143 0.0077
774 CONVULSION 439 0.0077
775 GASTRIC HAEMORRHAGE 88 0.0076
776 LYMPHOPENIA 108 0.0076
777 SKIN FISSURES 149 0.0076
778 MEMORY IMPAIRMENT 1047 0.0076
779 PRESCRIBED UNDERDOSE 152 0.0076
780 MALAISE 3340 0.0076
781 DEAFNESS 199 0.0076
782 CARDIAC DISORDER 711 0.0076
783 IMMUNE SYSTEM DISORDER 100 0.0076
784 RASH PAPULAR 170 0.0076
785 BONE MARROW FAILURE 154 0.0076
786 NEOPLASM 87 0.0076
787 JOINT STIFFNESS 198 0.0075
788 MACULAR DEGENERATION 90 0.0075
789 DIABETES MELLITUS INADEQUATE CONTROL 133 0.0075
790 OCULAR HYPERAEMIA 356 0.0075
791 PROCEDURAL PAIN 208 0.0075
792 PERITONITIS 155 0.0075
793 INCREASED APPETITE 143 0.0075
794 NEUROTOXICITY 131 0.0075
795 NERVOUSNESS 390 0.0075
796 JOINT RANGE OF MOTION DECREASED 100 0.0074
797 THERAPY CESSATION 382 0.0074
798 COGNITIVE DISORDER 347 0.0074
799 ACUTE MYELOID LEUKAEMIA 115 0.0074
800 MUSCLE TWITCHING 170 0.0074
801 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1324 0.0073
802 OFF LABEL USE 6430 0.0073
803 EMOTIONAL DISORDER 226 0.0073
804 ARTHROPATHY 406 0.0073
805 GASTRIC CANCER 185 0.0073
806 DEPRESSED MOOD 384 0.0073
807 ECZEMA 380 0.0073
808 DERMATITIS ALLERGIC 91 0.0072
809 MYELODYSPLASTIC SYNDROME 104 0.0072
810 BONE LOSS 108 0.0072
811 EXPIRED PRODUCT ADMINISTERED 237 0.0071
812 RASH GENERALISED 183 0.0071
813 TRANSAMINASES INCREASED 157 0.0071
814 MENTAL DISORDER 307 0.0070
815 DRUG TOXICITY 96 0.0070
816 INCORRECT DRUG ADMINISTRATION DURATION 198 0.0070
817 AGITATION 517 0.0070
818 PRODUCT ADMINISTRATION ERROR 142 0.0070
819 INTENTIONAL PRODUCT USE ISSUE 615 0.0070
820 IRRITABILITY 421 0.0070
821 FRACTURE 132 0.0070
822 MOBILITY DECREASED 501 0.0070
823 ADVERSE REACTION 92 0.0069
824 LOCAL SWELLING 121 0.0069
825 INFLAMMATION 357 0.0069
826 HUNGER 96 0.0069
827 JOINT SWELLING 826 0.0068
828 KNEE ARTHROPLASTY 144 0.0068
829 DISABILITY 135 0.0068
830 CONTRAINDICATED PRODUCT ADMINISTERED 206 0.0068
831 HOSPITALISATION 1045 0.0068
832 MUSCULOSKELETAL STIFFNESS 595 0.0068
833 PELVIC PAIN 123 0.0068
834 PRODUCT AVAILABILITY ISSUE 154 0.0068
835 PROSTATIC SPECIFIC ANTIGEN INCREASED 93 0.0067
836 CEREBROVASCULAR ACCIDENT 1141 0.0067
837 ACUTE HEPATIC FAILURE 92 0.0067
838 NEOPLASM PROGRESSION 233 0.0067
839 BLOOD GLUCOSE DECREASED 321 0.0067
840 MULTIPLE ORGAN DYSFUNCTION SYNDROME 189 0.0067
841 TREATMENT NONCOMPLIANCE 364 0.0066
842 EOSINOPHILIA 116 0.0066
843 PRESCRIBED OVERDOSE 128 0.0066
844 THINKING ABNORMAL 123 0.0066
845 INFLUENZA LIKE ILLNESS 543 0.0066
846 CRYING 239 0.0066
847 HYPERTHYROIDISM 95 0.0066
848 FREQUENT BOWEL MOVEMENTS 177 0.0065
849 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 359 0.0065
850 HAEMORRHAGE 683 0.0065
851 HIP ARTHROPLASTY 100 0.0065
852 GLYCOSYLATED HAEMOGLOBIN INCREASED 164 0.0065
853 SKIN EXFOLIATION 548 0.0065
854 PRODUCT USE ISSUE 1219 0.0065
855 INJECTION SITE RASH 196 0.0064
856 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 109 0.0064
857 HYPOKINESIA 92 0.0063
858 ACTIVITIES OF DAILY LIVING IMPAIRED 125 0.0063
859 MYOCARDIAL INFARCTION 1095 0.0063
860 LYMPHOMA 97 0.0063
861 MOVEMENT DISORDER 201 0.0063
862 HYPOACUSIS 269 0.0062
863 DISTURBANCE IN ATTENTION 335 0.0062
864 PARANOIA 107 0.0062
865 THERAPEUTIC RESPONSE DECREASED 376 0.0062
866 PRURITUS GENERALISED 134 0.0062
867 CARDIOVASCULAR DISORDER 157 0.0062
868 SKIN REACTION 87 0.0062
869 DRY SKIN 824 0.0062
870 MUSCULOSKELETAL DISORDER 117 0.0061
871 EYE DISORDER 202 0.0061
872 NIGHTMARE 211 0.0061
873 THERAPY PARTIAL RESPONDER 95 0.0061
874 MOOD ALTERED 166 0.0061
875 ABNORMAL DREAMS 167 0.0060
876 BLINDNESS UNILATERAL 85 0.0060
877 HEPATITIS 154 0.0060
878 DIABETIC KETOACIDOSIS 144 0.0060
879 INJECTION SITE SWELLING 459 0.0060
880 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 424 0.0060
881 SKIN CANCER 128 0.0059
882 SEDATION 155 0.0059
883 ILL-DEFINED DISORDER 359 0.0059
884 DRUG INTOLERANCE 566 0.0059
885 HALLUCINATION, AUDITORY 93 0.0058
886 OSTEONECROSIS 192 0.0058
887 DRUG INEFFECTIVE 7670 0.0058
888 EXPOSURE VIA SKIN CONTACT 150 0.0058
889 VISUAL IMPAIRMENT 717 0.0058
890 PRODUCT PRESCRIBING ISSUE 126 0.0058
891 GENERALISED TONIC-CLONIC SEIZURE 95 0.0057
892 ADVERSE DRUG REACTION 515 0.0057
893 SENSORY DISTURBANCE 92 0.0057
894 THERAPEUTIC RESPONSE SHORTENED 190 0.0057
895 INJECTION SITE REACTION 390 0.0057
896 MENTAL IMPAIRMENT 137 0.0056
897 NERVOUS SYSTEM DISORDER 176 0.0056
898 NEOPLASM MALIGNANT 375 0.0056
899 DERMATITIS ATOPIC 291 0.0055
900 INJECTION SITE PRURITUS 369 0.0055
901 RHEUMATOID ARTHRITIS 624 0.0055
902 GENERAL PHYSICAL HEALTH DETERIORATION 632 0.0055
903 ABNORMAL BEHAVIOUR 214 0.0054
904 INCORRECT DOSE ADMINISTERED 1213 0.0053
905 THERAPEUTIC PRODUCT EFFECT DECREASED 236 0.0053
906 SYSTEMIC LUPUS ERYTHEMATOSUS 187 0.0053
907 BLOOD GLUCOSE INCREASED 990 0.0052
908 DEATH 4435 0.0051
909 INJECTION SITE URTICARIA 126 0.0051
910 INJECTION SITE BRUISING 407 0.0051
911 INJECTION SITE ERYTHEMA 628 0.0051
912 SUICIDAL IDEATION 463 0.0051
913 SYNOVITIS 90 0.0050
914 BLOOD GLUCOSE ABNORMAL 92 0.0050
915 VISUAL ACUITY REDUCED 165 0.0050
916 ADVERSE EVENT 452 0.0049
917 MEDICATION ERROR 271 0.0049
918 PRODUCT SUBSTITUTION ISSUE 279 0.0048
919 NEEDLE ISSUE 141 0.0048
920 PSORIATIC ARTHROPATHY 194 0.0048
921 ABASIA 118 0.0048
922 PAIN OF SKIN 128 0.0047
923 MULTIPLE SCLEROSIS 227 0.0047
924 PRODUCT DOSE OMISSION 307 0.0047
925 NO ADVERSE EVENT 843 0.0046
926 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 940 0.0046
927 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 119 0.0046
928 EXTRA DOSE ADMINISTERED 187 0.0046
929 AGGRESSION 228 0.0046
930 ANGER 154 0.0045
931 INTENTIONAL PRODUCT MISUSE 398 0.0045
932 PRODUCT PRESCRIBING ERROR 108 0.0045
933 MULTIPLE SCLEROSIS RELAPSE 306 0.0045
934 BLINDNESS 181 0.0044
935 TARDIVE DYSKINESIA 125 0.0044
936 DYSTONIA 84 0.0043
937 DEVICE DISLOCATION 188 0.0043
938 UNDERDOSE 313 0.0043
939 PRODUCT DISPENSING ERROR 93 0.0043
940 MOOD SWINGS 136 0.0043
941 PSYCHOTIC DISORDER 125 0.0042
942 PANCREATIC CARCINOMA 122 0.0042
943 ERECTILE DYSFUNCTION 108 0.0042
944 LIVER INJURY 103 0.0042
945 INJECTION SITE PAIN 1284 0.0042
946 PHARMACEUTICAL PRODUCT COMPLAINT 108 0.0042
947 COMA 196 0.0041
948 COLITIS ULCERATIVE 183 0.0041
949 LUNG NEOPLASM MALIGNANT 168 0.0041
950 DRUG ADMINISTRATION ERROR 125 0.0041
951 DRUG EFFECT DECREASED 218 0.0040
952 MATERNAL EXPOSURE DURING PREGNANCY 359 0.0040
953 DEVICE ISSUE 353 0.0039
954 DRUG EFFECT INCOMPLETE 142 0.0039
955 EPILEPSY 117 0.0038
956 LOWER RESPIRATORY TRACT INFECTION 174 0.0038
957 PRODUCT QUALITY ISSUE 514 0.0038
958 VAGINAL HAEMORRHAGE 160 0.0037
959 OVERDOSE 769 0.0036
960 WRONG TECHNIQUE IN DRUG USAGE PROCESS 129 0.0035
961 DRUG DOSE OMISSION 585 0.0035
962 DEVICE MALFUNCTION 248 0.0035
963 EXTRAPYRAMIDAL DISORDER 87 0.0035
964 WITHDRAWAL SYNDROME 144 0.0034
965 PSORIASIS 441 0.0034
966 INJECTION SITE MASS 122 0.0033
967 DEVICE LEAKAGE 142 0.0033
968 TOXICITY TO VARIOUS AGENTS 548 0.0032
969 SKIN BURNING SENSATION 232 0.0032
970 ABORTION SPONTANEOUS 128 0.0032
971 INJECTION SITE HAEMORRHAGE 251 0.0031
972 ACCIDENTAL EXPOSURE TO PRODUCT 319 0.0031
973 ACNE 234 0.0031
974 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 219 0.0031
975 SUICIDE ATTEMPT 180 0.0030
976 RENAL CANCER 140 0.0029
977 SKIN IRRITATION 131 0.0029
978 MYELOSUPPRESSION 100 0.0028
979 DRUG EXPOSURE DURING PREGNANCY 94 0.0028
980 COMPLETED SUICIDE 228 0.0027
981 BREAST CANCER 226 0.0024
982 TREATMENT FAILURE 200 0.0024
983 PROSTATE CANCER 188 0.0023
984 DRUG WITHDRAWAL SYNDROME 199 0.0023
985 DEVICE BREAKAGE 92 0.0023
986 BLADDER CANCER 129 0.0022
987 PRODUCT STORAGE ERROR 190 0.0022
988 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 94 0.0020
989 FOETAL EXPOSURE DURING PREGNANCY 143 0.0018
990 INTENTIONAL OVERDOSE 109 0.0017
991 DEVICE DIFFICULT TO USE 94 0.0014
992 DRUG ABUSE 111 0.0013
993 DRUG DEPENDENCE 182 0.0011
994 DRUG DOSE OMISSION BY DEVICE 85 0.0011